Another week, another review, or even reviews. The latest HTA Review announcement confirmed new review processes on discount rates, comparators, and co-dependent pathways, which have all been repeatedly examined over the past decade. These endless bureaucratic reviews are about squeezing the life out of actual reform, like juice from a lemon. Meanwhile, patients keep paying the price for this Faustian pact, and for some, that means dying. …
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 11 September
September 11, 2026 - - Podcast -
Rare genetic motor neurone disease treatment finally reaches Australian patients
September 11, 2026 - - Latest News -
NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms
September 11, 2026 - - Latest News -
AI Health Summit 2026
September 10, 2026 - - Summit -
Taking a stake is not the same as spectating investor risk and expecting a benefit
September 10, 2026 - - Latest News -
Melbourne oncologist takes the reins at Australia's private cancer physicians body
September 10, 2026 - -
Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this
September 10, 2026 - - Latest News